EVLARCO

Serial Number 79422968
Registration 8026721
700

Registration Progress

Application Filed
Apr 3, 2025
Under Examination
Approved for Publication
Sep 24, 2025
Published for Opposition
Sep 30, 2025
Registered
Nov 18, 2025

Trademark Image

EVLARCO

Basic Information

Serial Number
79422968
Registration Number
8026721
Filing Date
April 3, 2025
Registration Date
November 18, 2025
Published for Opposition
September 30, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Nov 18, 2025
Registration
Registered
Classes
005

Rights Holder

NewAmsterdam Pharma B.V.

78
Address
Gooimeer 2 35
NL-1411 DC Naarden
NL

Ownership History

NewAmsterdam Pharma B.V.

Original Applicant
78
NL

NewAmsterdam Pharma B.V.

Owner at Publication
78
NL

NewAmsterdam Pharma B.V.

Original Registrant
78
NL

USPTO Deadlines

Next Deadline
2120 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20251118)
Due Date
November 18, 2031
Grace Period Ends
May 18, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

9 events
Date Code Type Description Documents
Dec 18, 2025 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Nov 18, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Sep 30, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 24, 2025 NPUB O NOTICE OF PUBLICATION Loading...
Sep 1, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 31, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
May 6, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
May 6, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 1, 2025 SDRC M SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for lowering cholesterol; pharmaceuticals, namely, lipid lowering agents; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders, major adverse cardiac events, cholesterol-related diseases and disorders, dyslipidemia, lipid-related diseases and disorders, diabetes, age-related macular degeneration, neurodegenerative diseases and disorders, dementia, lewy body dementia, and alzheimer's disease.

Classification

International Classes
005